Background Disorders of lipid metabolism play a key role in the initiation and progression of
chronic kidney disease (CKD). Recently, research on lipid metabolism in CKD has rapidly …

Aim We aimed to determine the macrovascular and microvascular outcomes of intensive
versus standard glucose‐lowering strategies in type 2 diabetes (T2D) and investigate the …

Background: Rosuvastatin and atorvastatin are the most widely prescribed moderate-to high-
intensity statins. However, evidence on their efficacy and safety during actual use is limited …

There is no reliable causal evidence for the effect of statins on diabetic nephropathy (DN)
and diabetic retinopathy (DR), and the results of previous observational studies are …

Background To examine the association of use of different antivirals with hospital-acquired
AKI among Chinese adults with herpes zoster. Methods This study selected 3273 adult …

Background Statins were regarded as a main medication for managing
hypercholesterolemia. Administration of statin therapy could reduce the incidence of …

Diabetic nephropathy (DN) is a major complication of diabetes. Nonalcoholic fatty liver
disease (NAFLD) is common in diabetes, and liver fibrosis is a prognostic risk factor for …

Introduction: There was limited research on the epidemiology of hyperphosphatemia in early-
stage chronic kidney disease (CKD) patients. We aimed to explore the clinical …

Diabetic vascular complications include diabetic macroangiopathy and diabetic
microangiopathy. Diabetic microangiopathy is characterised by impaired microvascular …

There has been substantial research interest in finding activities/agents that slow the onset
and reduce the severity of numerous age-related diseases/conditions. This assessment …